At its pharmaceutical facility located in Ireland, deDanú will extract and process bulk biomass supplied by Melabis, which has over 3,000 hectares of accessible organic cultivation under contract.
Alexzander Samuelsson, Melabis Chief Science Officer, has years of experience in innovation and development of extraction and processing in the Canadian cannabis sector and will provide on site support to deDanú for its extraction and processing operations.
With the production of quality assured products in Ireland, this strategic partnership represents significant revenues for both companies, with distribution opportunities throughout Europe and Asian markets.
Damon Booth, founder of Melabis, said “It is partnerships like these that will really set Melabis apart from the bulk growers that are coming into the space now. We have immense cultivation capabilities and need companies of deDanu’s calibre to ensure that our product can be processed efficiently to pharmaceutical standards.”
“Ireland has the infrastructure and skilled labour force to produce premium grade products,” said Leah Fletcher, founder & CEO of deDanú, “we are the largest exporter of pharmaceutical goods in the EU and deDanú is one of the first operations of its kind in Western Europe. We are global contenders in this emerging industry and are excited to be working with Melabis.”
Located in the Irish Midlands, deDanú Limited is the largest commercial cultivator of organic hemp in Ireland and operates one of the first pharmaceutical facilities dedicated to the research, innovation and production of cannabinoids in Western Europe. Previously used for research and GMP/ISO certified manufacturing, deDanú’s facility houses two laboratories for testing and research and has the capacity to manufacture pharmaceutical grade hemp derived products.